SPY424.31+0.70 0.17%
DIA345.12+0.14 0.04%
IXIC14,069.42+49.09 0.35%

Redburn Partners Initiates Coverage On Beam Therapeutics with Buy Rating

Redburn Partners initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Buy rating.

05/11/2021 07:50
Redburn Partners initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Buy rating.